About Asymchem
Asymchem is a company based in Morrisville (United States) founded in 1995. The company has 48 employees as of December 31, 2022. Asymchem has completed 1 acquisition, including Snapdragon Chemistry. Asymchem operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Morrisville, United States
- Employees 48 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$330.56 M (USD), Post-IPO
Feb 17, 2020
- Investors
-
Employee Count
48
as on Dec 31, 2022
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Asymchem
Unlock access to complete
Funding Insights of Asymchem
Investors in Asymchem
Asymchem has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Hillhouse.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed with long-term focus.
|
Locked | Locked | Locked |
Investor details for Asymchem
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Asymchem
Asymchem has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Snapdragon Chemistry.
Investment portfolio details for Asymchem
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug discovery and development service provider
|
Locked | Locked | 2014 | Locked |
Complete acquisition details for Asymchem
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Asymchem
Detailed financials for Asymchem
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Asymchem Comparisons
Peer comparison for Asymchem
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Asymchem
Asymchem operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
Detailed competitors of Asymchem
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Asymchem
Complete news archive for Asymchem
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Asymchem
Asymchem was founded in 1995 and raised its 1st funding round 25 years after it was founded.
Asymchem is headquartered in Morrisville, United States.
As of Dec 31, 2022, the latest employee count at Asymchem is 48.
Asymchem is focussed on the process development and commercial manufacturing of APIs and peptides. Their facilities have been approved by USFDA and Australian TGA for API manufacturing and CFDA for drug product manufacturing. They claim that they have an added advantage of in-house raw materials manufacturing, through which they can control availability and lead-times. Asymchem offers services such as process optimization, pilot manufacturing and DMF filing of peptides and peptide containing drugs. They offer FDF services such as Blending, Encapsulation, Granulation wet granulation, roller compaction and fluid bed granulation, Fluid bed drying, Particle coating, Tablet compression, Tablet film coating immediate and modified release film coat for oral solid dosage forms. They also offer pre-formulation, formulation development, analytical services and stability studies. The companys capabilities include continuous flow reactions technologies, biocatalysis, asymmetric synthesis, Highly Potent APIs, cryogenic, catalytic hydrogenation, etc.,.
Asymchem's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Asymchem has made 1 acquisition, including Snapdragon Chemistry.
Asymchem has 1 investor. Key investors include Hillhouse.